We thought the answer was YES.
There is no reason to think that the UK population response to diabetic treatment and control of risk factors would be radically different from that of the US population.
However we must be cautious about the data for glycaemic control because of the uncertainty, noted above, about the extent to which the treatment of diabetes represents current practice.